Analytical Similarity Assessment in Biosimilar Product Development | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
A01=Shein-Chung Chow
Age Group_Uncategorized
Age Group_Uncategorized
Author_Shein-Chung Chow
automatic-update
Category1=Non-Fiction
Category=MBGR1
Category=MBNS
Category=MMG
Category=PS
Category=TDCW
COP=United Kingdom
Delivery_Pre-order
Language_English
PA=Temporarily unavailable
Price_€50 to €100
PS=Active
softlaunch

Analytical Similarity Assessment in Biosimilar Product Development

English

By (author): Shein-Chung Chow

This book focuses on analytical similarity assessment in biosimilar product development following the FDAs recommended stepwise approach for obtaining totality-of-the-evidence for approval of biosimilar products. It covers concepts such as the tiered approach for assessment of similarity of critical quality attributes in the manufacturing process of biosimilar products, models/methods like the statistical model for classification of critical quality attributes, equivalence tests for critical quality attributes in Tier 1 and the corresponding sample size requirements, current issues, and recent developments in analytical similarity assessment.

See more
Current price €59.84
Original price €62.99
Save 5%
A01=Shein-Chung ChowAge Group_UncategorizedAuthor_Shein-Chung Chowautomatic-updateCategory1=Non-FictionCategory=MBGR1Category=MBNSCategory=MMGCategory=PSCategory=TDCWCOP=United KingdomDelivery_Pre-orderLanguage_EnglishPA=Temporarily unavailablePrice_€50 to €100PS=Activesoftlaunch

Will deliver when available.

Product Details
  • Weight: 650g
  • Dimensions: 156 x 234mm
  • Publication Date: 18 Dec 2020
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9780367733834

About Shein-Chung Chow

AuthorShein-Chung Chow Ph.D is currently an Associate Director at Office ofBiostatistics Center for Drug Evaluation and Research United States Foodand Drug Administration (FDA). Prior to joining FDA Dr. Chow was aProfessor at Duke University School of Medicine Durham NC. He wasalso a special government employee (SGE) appointed by the FDA as anAdvisory Committee member and statistical advisor to the FDA. Prior tothat Dr. Chow also held various positions in the pharmaceutical industrysuch as Vice President at Millennium Cambridge MA Executive Director atCovance Princeton NJ and Director and Department Head at Bristol-MyersSquibb Plainsboro NJ. Dr. Chow is the Editor-in-Chief of the Journal ofBiopharmaceutical Statistics and the Editor-in-Chief of the Biostatistics Book Seriesat Chapman and Hall/CRC Press Taylor & Francis Group. He was electedFellow of the American Statistical Association and an elected member of theISI (International Statistical Institute). Dr. Chow is the author or co-author ofover 300 methodology papers and 29 books including Designs and Analysisof Bioavailability and Bioequivalence Studies Sample Size Calculations in ClinicalResearch Adaptive Design Methods in Clinical Trials Translational MedicineDesign and Analysis of Clinical Trials and Quantitative Methods for TraditionalChinese Medicine Development.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept